about
Telomerase reverse transcriptase (TERT) rs2736100 polymorphism contributes to increased risk of glioma: evidence from a meta-analysisTrend of telomerase activity change during human iPSC self-renewal and differentiation revealed by a quartz crystal microbalance based assay.mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete.Natural and pharmacological regulation of telomeraseA functional tandem-repeats polymorphism in the downstream of TERT is associated with the risk of nasopharyngeal carcinoma in Chinese population.Clinical utility of telomerase in cancer.Telomerase in human tumors: molecular diagnosis and clinical significance.Telomerase RNA accumulates in Cajal bodies in human cancer cells.Chondrocyte senescence and telomere regulation: implications in cartilage aging and cancer (a brief review).Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangiocytes.Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle.Assessment of telomere length and factors that contribute to its stability.Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one.Influence of the hTERT rs2736100 polymorphism on telomere length in gastric cancer.AZT as a telomerase inhibitor.The role of peroxisome proliferator-activated receptors in colorectal cancer.Hepatitis B virus X gene induces human telomerase reverse transcriptase mRNA expression in cultured normal human cholangiocytes.Design of a ribozyme targeting human telomerase reverse transcriptase and cloning of it's gene.Newer developments in immunohistologyTelomere structure and telomerase in health and disease (review).Primary cutaneous carcinosarcoma: case report with expanded immunohistochemical analysis.MR molecular imaging of tumours using ferritin heavy chain reporter gene expression mediated by the hTERT promoter.Formation of a unique end-to-end stacked pair of G-quadruplexes in the hTERT core promoter with implications for inhibition of telomerase by G-quadruplex-interactive ligands.ERalpha increases expression and interacts with TERT in cataractous canine lens epithelial cells.Tackling hepatitis B virus-associated hepatocellular carcinoma--the future is now.Antisense epidermal growth factor receptor RNA transfection in human glioblastoma cells down-regulates telomerase activity and telomere length.Effects of N-(4-hydroxyphenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers.Targeting telomerase with radiolabeled inhibitors.The relationship between telomere length and clinicopathologic characteristics in colorectal cancers among Tunisian patients.Association of telomerase activity with radio- and chemosensitivity of neuroblastomas.Protein phosphatase 2A (PP2A) has a potential role in CAPE-induced apoptosis of CCRF-CEM cells via effecting human telomerase reverse transcriptase activity.Effects of cotransfection of antisense-EGFR and wild-type PTEN cDNA on human glioblastoma cells.Upregulation of human telomerase reverse transcriptase mRNA expression by in vitro transfection of hepatitis B virus X gene into human hepatocarcinoma and cholangiocarcinoma cellsTelomerase detection in the diagnosis and prognosis of cancer.Telomerase catalytic subunit in laryngeal carcinogenesis--an immunohistochemical study.Expression of human telomerase catalytic protein in gallbladder carcinogenesis.Inhibition of telomerase activity in endometrial cancer cells by selenium-cisplatin conjugate despite suppression of its DNA-damaging activity by sodium ascorbate.Telomere length is a prognostic factor for overall survival in colorectal cancer.Human telomerase catalytic subunit gene re-expression is an early event in oral carcinogenesis.A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.
P2860
Q28389818-852AB143-734D-43AD-911A-D2C3393BD4FEQ30426021-27364BEB-09CA-40E4-A732-ADE5346D9EAFQ30486814-E06E8437-859E-46AF-8E5B-A7B72630E01AQ31038583-FF1CACAC-94A6-4149-AC72-F7CCE0A04763Q34022398-D67BFCA1-0369-4C6A-8B32-A778ADC7000AQ34535693-80306A7D-D96F-4360-B02D-BA9098CC9B96Q34569258-384A629E-31E9-4E4B-8580-6525DA54780FQ34785598-05AAC1AD-B67D-4691-8A96-2F518D9A6C2FQ34785917-70F2FC36-70EA-4745-88A0-5CCB51CD9022Q34882042-DB17846B-20C7-4520-8090-FAD329E834E1Q35002186-17BBC2C3-5F81-410F-ACB8-038892265A68Q35050968-B134EEE0-FF06-4317-A573-626E9318CA64Q35886889-23C852AD-901C-41F8-9854-0FFDA0E0C342Q35970136-840D0D10-AA15-4531-933F-F47CE2AB177AQ36210474-04FCEC65-72CB-4ACE-A54B-CF7CD5D4E681Q36248494-F15154BC-64A8-4917-A70C-661F135C96D1Q36496460-7A6CDA6F-A084-4DB4-B565-1E679466B7CCQ36506281-1F8B721E-9ED3-4935-AA1C-B590DA4F2316Q36637725-ADC28A13-C4C2-456C-AEC3-3CA83C583B41Q36643073-D62B290F-5546-4D27-9535-5E56C427B0B5Q37138604-BA2B752F-840D-49E0-B7FF-D94032DABF10Q37314214-6E7F7C46-A645-4ADD-99B6-450A89590C1BQ37385440-38CB6CF9-E85C-471E-8822-75B8D95FB5C1Q37418978-EF93F9B4-FC25-4D32-BB99-B930C4D7B565Q38056849-7ED0BED6-B828-4352-A71C-1A8DCE64FC23Q38283106-26D3FBAA-2075-49FD-877F-817385319313Q38524471-64A6BADD-9EC2-49F8-93D9-989ADD4A8308Q38744397-08778BC0-FD79-4F51-BE9F-E1AA0A7DCA84Q39286522-AD155854-6C45-4D0E-B432-D4B5E104AC30Q39678514-5CD384A0-1051-4BA3-8132-E38B31C60071Q40081656-36EFD0CE-361A-4D68-B5E8-D6F19239D964Q40268565-CE680550-6FA8-449D-8970-4A584DEAF028Q40359921-55DEF089-8143-4F18-A70F-45002D0077E6Q42183561-F5201A9A-62D2-4EAB-85B9-5A6115AABAADQ42467776-E800F50B-AF1A-46CF-91A3-48B5A7D7595BQ43009940-B26EC9D4-9CD8-44EC-A366-EA374DE227CAQ43831688-929E0DEC-220F-4F05-AECF-4976FE2E6EC4Q44551562-C99DCC44-3FDD-4C0A-96E0-D6B94D3EF95BQ47262005-20DE1BF1-745D-43CE-813F-715FBD33DCF0Q51065162-87369197-E817-4092-9666-BC2183308ED3
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Telomeres, telomerase and cancer: an up-date.
@ast
Telomeres, telomerase and cancer: an up-date.
@en
Telomeres, telomerase and cancer: an up-date.
@nl
type
label
Telomeres, telomerase and cancer: an up-date.
@ast
Telomeres, telomerase and cancer: an up-date.
@en
Telomeres, telomerase and cancer: an up-date.
@nl
prefLabel
Telomeres, telomerase and cancer: an up-date.
@ast
Telomeres, telomerase and cancer: an up-date.
@en
Telomeres, telomerase and cancer: an up-date.
@nl
P2093
P356
P1433
P1476
Telomeres, telomerase and cancer: an up-date.
@en
P2093
Parwaresch R
Van Marck E
P2888
P356
10.1007/S004280000189
P577
2000-07-01T00:00:00Z